CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −719 | $577.54 | $415K | 21,396 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,160 | $579.13 | $672K | 20,236 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −440 | $580.26 | $255K | 19,796 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −520 | $581.28 | $302K | 19,276 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −400 | $582.29 | $233K | 18,876 |
| 2026-05-04 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −10,000 | 32,500 | ||
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $568.36 | $23K | 49,973 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $569.64 | $68K | 49,853 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −40 | $570.99 | $23K | 49,813 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −440 | $572.42 | $252K | 49,373 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −359 | $574.37 | $206K | 49,014 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,320 | $575.45 | $760K | 47,694 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,677 | $576.39 | $2.1M | 44,017 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,039 | $577.26 | $600K | 42,978 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $578.58 | $93K | 42,818 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,104 | $579.27 | $640K | 41,714 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −560 | $580.98 | $325K | 41,154 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −401 | $581.78 | $233K | 40,753 |
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $582.30 | $140K | 40,513 |
Page 112 of 121 · 2,404 trades